Cargando…
Epicutaneous allergen application preferentially boosts specific T cell responses in sensitized patients
The effects of epicutaneous allergen administration on systemic immune responses in allergic and non-allergic individuals has not been investigated with defined allergen molecules. We studied the effects of epicutaneous administration of rBet v 1 and rBet v 1 fragments on systemic immune responses i...
Autores principales: | Campana, Raffaela, Moritz, Katharina, Neubauer, Angela, Huber, Hans, Henning, Rainer, Brodie, Tess M., Kaider, Alexandra, Sallusto, Federica, Wöhrl, Stefan, Valenta, Rudolf |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5599525/ https://www.ncbi.nlm.nih.gov/pubmed/28912492 http://dx.doi.org/10.1038/s41598-017-10278-1 |
Ejemplares similares
-
Frequent occurrence of T cell–mediated late reactions revealed by atopy patch testing with hypoallergenic rBet v 1 fragments
por: Campana, Raffaela, et al.
Publicado: (2015) -
Heat‐labile Escherichia coli toxin enhances the induction of allergen‐specific IgG antibodies in epicutaneous patch vaccination
por: Cabauatan, C. R., et al.
Publicado: (2016) -
Induction of allergen-specific blocking IgG using patch delivered recombinant Bet v 1 in guinea pigs
por: Cabauatan, Clarissa, et al.
Publicado: (2014) -
Vaccine development for allergen-specific immunotherapy based on recombinant allergens and synthetic allergen peptides: Lessons from the past and novel mechanisms of action for the future
por: Valenta, Rudolf, et al.
Publicado: (2016) -
Recombinant allergy vaccines based on allergen-derived B cell epitopes
por: Valenta, Rudolf, et al.
Publicado: (2017)